Title: Therapeutic Modulation of the Fas Pathway
Patent Number: 7,749,977
Filed: Oct. 24, 2006
Lead Inventor: Fruma Yehiely, Quark Pharmaceuticals
The invention, the patent's abstract states, comprises "a method for the identification of genes that are essential for the maintenance of specific cell phenotypes. …The method includes the initial step of identifying a cell type with a phenotype of interest.